pantoprazole
(pan toe' pray zol)
Pantoloc (CAN), Protonix, Protonix IV
Pregnancy Category B
Drug classes
Antisecretory drug
Proton pump inhibitor
Therapeutic actions
Gastric acid-pump inhibitor: Suppresses gastric acid secretion by specific inhibition of the hydrogen-potassium ATPase enzyme system at the secretory surface of the gastric parietal cells; blocks the final step of acid production.
Indications
· Oral: Short-term (< 8 wk) and long-term treatment of GERD
· Maintenance healing of erosive esophagitis
· Long-term treatment of pathological hypersecretory conditions
· IV: Short-term (7–10 days) treatment of GERD in patients unable to continue oral therapy
· Treatment of pathological hypersecretory conditions associated with Zollinger-Ellison syndrome and other neoplastic conditions
· Unlabeled uses: Treatment of duodenal ulcer
Contraindications and cautions
· Contraindicated with hypersensitivity to any proton pump inhibitor or any drug components.
· Use cautiously with pregnancy, lactation.
Available forms
DR tablet—20, 40 mg; powder for injection—40 mg/vial
Dosages
ADULTS
40 mg PO daily for maintenance healing of erosive esophagitis for < 8 wk. 8-wk course may be repeated if healing has not occurred; give continually for hypersecretory disoders; 40 mg/day IV for 7–10 days. Up to 240 mg/day PO or IV has been used for hypersecretory syndromes.
PEDIATRIC PATIENTS < 18 YR
Safety and efficacy not established.
PATIENTS WITH HEPATIC IMPAIRMENT
Use caution and monitor patient closely.
Pharmacokinetics
Route | Onset | Peak |
Oral | 1 hr | 3–5 hr |
IV | Rapid | 3–5 hr |
Metabolism: Hepatic; T1/2: 1.5 hr
Distribution: Crosses placenta; may enter breast milk
Excretion: Bile, urine
IV facts
Preparation: Reconstitute with 10 mL 0.9% sodium chloride; may then be further diluted with 100 mL 5% dextrose injection, 0.9% sodium chloride injection or lactated Ringer's, final concentration 0.4 mg/mL; reconstituted solution can be stored 2 hr, dilution up to 12 hr at room temperature.
Infusion: Infuse over at least 15 min using in-line filter.
Incompatibilities: Do not mix with or administer through the same line as other IV solutions.
Adverse effects
· CNS: Headache, dizziness, asthenia, vertigo, insomnia, apathy, anxiety, paresthesias, dream abnormalities
· Dermatologic: Rash, inflammation, urticaria, pruritus, alopecia, dry skin
· GI: Diarrhea, abdominal pain, nausea, vomiting, constipation, dry mouth, tongue atrophy
· Respiratory: URI symptoms, cough, epistaxis
· Other: Cancer in preclinical studies, back pain, fever
Interactions
Drug-drug
· Fewer drug interactions reported than with other proton pump inhibitors
Nursing considerations
Assessment
· History: Hypersensitivity to any proton pump inhibitor or any drug components; pregnancy; lactation
· Physical: Skin lesions; T; reflexes, affect; urinary output, abdominal examination; respiratory auscultation
Interventions
· Administer once or twice a day. Caution patient to swallow tablets whole; not to cut, chew, or crush them.
· WARNING: Arrange for further evaluation of patient after 4 wk of therapy for gastroreflux disorders. Symptomatic improvement does not rule out gastric cancer; gastric cancer did occur in preclinical studies.
· Maintain supportive treatment as appropriate for underlying problem.
· Switch patients on IV therapy to oral dosage as soon as possible.
· Provide additional comfort measures to alleviate discomfort from GI effects and headache.
Teaching points
· Take the drug once or twice a day. Swallow the tablets whole—do not chew, cut, or crush them.
· Arrange to have regular medical follow-up care while you are using this drug.
· Maintain all of the usual activities and restrictions that apply to your condition. If this becomes difficult, consult your health care provider.
· You may experience these side effects: Dizziness (avoid driving a car or performing hazardous tasks); headache (consult your health care provider if these become bothersome, medications may be available to help); nausea, vomiting, diarrhea (proper nutrition is important, consult a dietitian to maintain nutrition; stay near a bathroom); symptoms of upper respiratory tract infection, cough (it may help to know that this is a drug effect, do not self-medicate, consult your health care provider if this becomes uncomfortable).
· Report severe headache, worsening of symptoms, fever, chills, blurred vision, periorbital pain.
Adverse effects in Italic are most common; those in Bold are life-threatening.
0 comments:
Post a Comment